Developability

Streamlining Drug Development with Integrated In Silico and Laboratory Developability Assessments

Andrea Arsiccio, Ph.D.,; Eva Keilhauer, Ph.D.; Kristian Le Vay, Ph.D.

Coriolis Pharma

Biologics Formulation

Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform

Pawel Stanczak, Ph.D.

Tanvex CDMO

Translation

The Translational Index Score: Improving the Entire Drug Development Cycle

Jo Varshney, Ph.D., D.V.M.

Generative AI

Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat

Petrina Kamya, Ph.D.

Insilico Medicine

Antibiotic Resistance

Antibiotic Resistance: Advances in Understanding and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

mRNA

The Intersection of mRNA Biology and Artificial Intelligence is Yielding Unique mRNA Drug Candidates

Yochi Slonim

Anima Biotech Inc.

Drug Discovery

Designing More Effective Therapeutic Proteins Using an Integrated Laboratory and Computational Platform

Peyton Greenside; Mark DePristo

BigHat Biosciences

Cancer Therapies

Computational Discoveries for Clinical Development of Novel Cancer Therapies

David Alvaro, Ph.D.; Anat Cohen-Dayag, Ph.D.

Pharma's Almanac